NIH licensed COVID-19 research tools and early-stage technologies to WHO program
On May 12, 2022, the U.S. National Institutes of Health announced that it had licensed 11 COVID-19 research…
On May 12, 2022, the U.S. National Institutes of Health announced that it had licensed 11 COVID-19 research…
On May 11, 2022, Lucira Health announced that it had submitted a request to the U.S. Food and…
On May 9, 2022, Lucira Health announced that both its COVID-19 & Flu and COVID-19 molecular tests have…
On May 7, 2022, WHO was informed of a confirmed case of monkeypox in an individual who travelled…
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
On May 5, 2022, the World Health Organization (WHO) reported estimates that show the full death toll associated…
On May 4, 2022, Oxitec announced approval from the Florida Department of Agriculture and Consumer Services, including reviews…
On Apr. 30, 2022, the U.S. Department of Agricultureメs Animal and Plant Health Inspection Service confirmed the presence…
On Apr. 29, 2022, the U.S. Department of Agricultureメs Animal and Plant Health Inspection Service confirmed the the…
On Apr. 27, 2022, the U.S. Department of Agricultureメs Animal and Plant Health Inspection Service (APHIS) announced that…
On Apr. 27, 2022, the U.S. Department of Agricultureメs Animal and Plant Health Inspection Service announced it had…
he Evolution of DNA is an Illustration with the very small, requiring magnification, to the very large. Cast…
On Apr. 25, 2022, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) had approved a…
On Apr. 21, 2022, CureVac announced preclinical data demonstrating immune responses and protective efficacy of a bivalent second-generation…
On Apr. 20, 2022, Codiak BioSciences announced new preclinical data from its pan beta-coronavirus vaccine program, which aims…
On Apr. 20, 2022, Tonix Pharmaceuticals announced the results of a retrospective observational database study in over 50,000…
On Apr. 16, 2022, the U.S. Department of Agricultureメs Animal and Plant Health Inspection Service confirmed the presence…
On Mar. 14, 2022, Pfizer and BioNTech announced positive results from a Phase 2/3 clinical trial evaluating the…
On Nov. 12, 2021, Regeneron announced that the U.S. Food and Drug Administration had extended by three months…
On Apr. 14, 2022, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the…
On Apr. 14, 2022, Merck announced that V116, the companyメs investigational 21-valent pneumococcal conjugate vaccine, had received Breakthrough…
On Apr. 13, 2022, the U.S. Food and Drug Administration announced that the legislation clarifying the agency can…
On Apr. 12, 2022, the Province of Alberta poultry reported that farms had tested positive for highly pathogenic…
On Apr. 11, 2022, CureVac and GSK announced that they had entered into a contract with the German…
On Apr. 11, 2022, Veru announced positive efficacy and safety results from a planned interim analysis of the…
On Apr. 9, 2022, BioNTech announced it was granted a pandemic preparedness contract by the Federal Republic of…
On Mar. 9, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced four grant awards to…
On Mar. 31, 2022, Sorrento Therapeutics announced that the FDA had given clearance to commence the Phase 3…
On Mar. 30, 2022, CureVac announced that the first participant was dosed in a Phase 1 study of…
On Mar. 26, 2022, the U.S. Department of Agricultureメs Animal and Plant Health Inspection Service confirmed the presence…